March 2026
1. RUMMEL KA, Hallemeier CL, Jin Z, Merrell KW, et al
   The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma.
   Am J Clin Oncol. 2026;49:105-112.
   

   >> Share

   
   June 2025
2. SUN J, Fredette JD, Hasler JS, Vu JV, et al
   Effect of Rectal Cancer Treatment Timing Standardization on Patient Outcomes.
   Am J Clin Oncol. 2025;48:302-309.
   

   >> Share

   
   May 2025
3. ZHAO Z, Yuan Z, Li Y, Huang X, et al
   The Balance and Imbalance of Microbial Communities: Oral-Gut Microbiota and Colorectal Cancer.
   Am J Clin Oncol. 2025 May 5. doi: 10.1097/COC.0000000000001213.
   

   >> Share

   
   March 2025
4. MUNOZ C, Riesco Martinez MC, Ugidos L, Garcia-Alfonso P, et al
   Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program.
   Am J Clin Oncol. 2025;48:142-147.
   

   >> Share

   
   February 2025
5. FIORICA F, Mandara M, Giuliani J, Tebano U, et al
   Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist: A Meta-analysis.
   Am J Clin Oncol. 2025;48:83-91.
   

   >> Share

   
   December 2024
6. SANCHEZ JI, Doose M, Zeruto C, Chollette V, et al
   Assessing the Impact of Multidisciplinary Cancer Consultations on Cancer Quality Metrics.
   Am J Clin Oncol. 2024;47:595-606.
   

   >> Share

   
   September 2024
7. RITTER AR, Prasad RN, Jhawar SR, Bazan JG, et al
   Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
   Am J Clin Oncol. 2024;47:434-438.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share